Segura, J., Pichini, S., Peng, S.H
The oxidoreductase of the IMS is Mia40
After its initial release for Windows systems, several Half-Life ports were developed for additional platforms, including the Playstation 2, Macintosh and Dreamcast
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
In particular, erythrocyte structure (visible structural membrane changes and eryptosis initiation) was notably affected by IL-8 [269]